A pharmacoepidemiological study of Rivaroxaban use and potential adverse outcomes in routine clinical pratice in Germany First published 01/10/2015 Last updated 08/07/2024 EU PAS number:EUPAS11145 Study Finalised
Leibniz Institute for Prevention Research and Epidemiology - BIPS Germany First published:29/03/2010 Last updated 26/02/2024 Institution Not-for-profit ENCePP partner